Zobrazeno 1 - 10
of 402
pro vyhledávání: '"Marco Matucci-Cerinic"'
Autor:
Dinesh Khanna, Christopher P. Denton, Daniel E. Furst, Maureen D. Mayes, Marco Matucci‐Cerinic, Vanessa Smith, Dick de Vries, Paul Ford, Yasmina Bauer, Matthew J. Randall, Mitra Ebrahimpoor, Laszlo Kupcsik, Pieter‐Jan Stiers, Liesbeth Deberdt, Niyati Prasad, Sharlene Lim, Philippe Pujuguet, Sohail Ahmed
Publikováno v:
Arthritis & Rheumatology.
Autor:
Weijin Zhang, Guohai Huang, Kedi Zheng, Jianqun Lin, Shijian Hu, Shaoyu Zheng, Guangzhou Du, Guohong Zhang, Cosimo Bruni, Marco Matucci-Cerinic, Daniel E. Furst, Yukai Wang
Publikováno v:
Clinical and Experimental Rheumatology.
Autor:
Corrado Campochiaro, Nicola Farina, Giacomo De Luca, Giorgia Trignani, Alessandro Tomelleri, Marco Matucci-Cerinic, Lorenzo Dagna
Publikováno v:
The Journal of Rheumatology. 50:151-153
Autor:
Corrado Campochiaro, Giacomo De Luca, Maria-Grazia Lazzaroni, Giuseppe Armentaro, Amelia Spinella, Barbara Vigone, Barbara Ruaro, Anna Stanziola, Devis Benfaremo, Enrico De Lorenzis, Beatrice Moccaldi, Silvia Laura Bosello, Giovanna Cuomo, Lorenzo Beretta, Elisabetta Zanatta, Dilia Giuggioli, Nicoletta Del Papa, Paolo Airo, Marco Confalonieri, Gianluca Moroncini, Lorenzo Dagna, Marco Matucci-Cerinic
IntroductionNintedanib (NTD) has been shown to be effective in systemic sclerosis (SSc)-interstitial lung disease (ILD). Here we describe the efficacy and safety of NTD in a real-life setting.MethodsPatients with SSc-ILD treated with NTD were retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b84ef2bf90800f561dffff49d0e031f6
https://hdl.handle.net/11577/3481905
https://hdl.handle.net/11577/3481905
Autor:
Virginia D. Steen, Margarida Alves, Manuel Quaresma Lic, Yannick Allanore, Dinesh Khanna, Christopher P. Denton, Oliver Distler, Elizabeth R. Volkmann, Marco Matucci-Cerinic, Corinna Miede, Maureen D. Mayes, Martina Gahlemann, Jörg H W Distler, Masataka Kuwana
Publikováno v:
Arthritis & Rheumatology. 74:518-526
Using data from the SENSCIS trial, these analyses were undertaken to assess the effects of nintedanib versus placebo in subgroups of patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), based on characteristics previously
Autor:
Vanessa Smith, Gemma Lepri, Silvia Bellando-Randone, Marco Matucci-Cerinic, Tünde Minier, Yannick Allanore, László Czirják, Francesco Del Galdo, Daniel E. Furst, Jérôme Avouac, Serena Guiducci, Maurizio Cutolo, Dörte Huscher, C. Bruni, Oliver Distler
Publikováno v:
The Lancet Rheumatology. 3:e834-e843
Summary Background Preliminary criteria for the very early diagnosis of systemic sclerosis (VEDOSS) have been previously proposed to identify signs and symptoms in patients with Raynaud's phenomenon. Patients with all signs or symptoms of the VEDOSS
Autor:
Yukai Wang, Qisheng Lin, Daniel E. Furst, Guohong Zhang, Chengpeng Zhang, Miaotong Su, Marco Matucci-Cerinic, Changhao Lu, Sini Gao, Jing Wang, Jianqun Lin, Xuezhen Xie
Publikováno v:
Annals of the Rheumatic Diseases. 81:379-385
ObjectivesRheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and primary Sjögren’s syndrome (pSS) share many clinical manifestations and serological features. The aim of this study was to identify the common transcriptional profiling an
Publikováno v:
Rheumatology International
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by fibrosis of the skin and internal organs, autoimmunity-driven damage and vasculopathy. The current approved disease-modifying treatments have limited efficacy, a
Autor:
Gemma Lepri, Paolo Airò, Oliver Distler, Kristofer Andréasson, Yolanda Braun-Moscovici, Eric Hachulla, Alexandra Balbir-Gurman, Ellen De Langhe, Simona Rednic, Francesca Ingegnoli, Edoardo Rosato, Laura Groseanu, Ruxandra Ionescu, Silvia Bellando-Randone, Liudmila Garzanova, Lorenzo Beretta, Chiara Bellocchi, Sergey Moiseev, Pavel Novikov, Iulia Szabo, Dorota Krasowska, Veronica Codullo, Ulrich A. Walker, Chrysoula Manolaraki, Serena Guiducci, Marie-Elise Truchetet, Florenzo Iannone, Lorenzo Tofani, Cosimo Bruni, Vanessa Smith, Giovanna Cuomo, Martin Krusche, Marco Matucci-Cerinic, Yannick Allanore
Publikováno v:
Journal of Scleroderma and Related Disorders. :239719832311559
Background: Several studies described the cross-sectional characteristics of systemic sclerosis patients and coexisting primary biliary cholangitis, but longitudinal prognostic data are lacking. Aims: To describe the systemic sclerosis–primary bili
Autor:
Cosimo Bruni, Maya H Buch, Aleksandra Djokovic, Giacomo De Luca, Raluca B Dumitru, Alessandro Giollo, Ilaria Galetti, Alexia Steelandt, Konstantinos Bratis, Yossra Atef Suliman, Ivan Milinkovic, Anna Baritussio, Ghadeer Hasan, Anastasia Xintarakou, Yohei Isomura, George Markousis-Mavrogenis, Sophie Mavrogeni, Luna Gargani, Alida LP Caforio, Carsten Tschöpe, Arsen Ristic, Sven Plein, Elijah Behr, Yannick Allanore, Masataka Kuwana, Christopher P Denton, Daniel E Furst, Dinesh Khanna, Thomas Krieg, Renzo Marcolongo, Alessia Pepe, Oliver Distler, Petros Sfikakis, Petar Seferovic, Marco Matucci-Cerinic
Publikováno v:
Journal of Scleroderma and Related Disorders. :239719832311634
Introduction: Heart involvement is a common problem in systemic sclerosis. Recently, a definition of systemic sclerosis primary heart involvement had been proposed. Our aim was to establish consensus guidance on the screening, diagnosis and follow-up